Rousseau E J, Davison A J, Dunn B
Bioenergetics Research Laboratory, School of Kinesiology, Faculty of Applied Sciences, Simon Fraser University, Burnaby, BC, Canada.
Free Radic Biol Med. 1992 Oct;13(4):407-33. doi: 10.1016/0891-5849(92)90183-h.
beta-Carotene protects against photooxidative dermatitis in porphyric humans and mice by quenching of photoactivated species. Other actions of beta-carotene in vivo are explained on the basis of its ability to scavenge free radicals in vitro. For example, in guinea pigs treated with CCl4, beta-carotene decreases pentane and ethane production. Epidemiological studies link low serum beta-carotene levels to elevated risk of lung and other cancers, and in intervention trials, beta-carotene diminishes preneoplastic lesions. However, the dose/response relationships are not well established, and antineoplastic mechanisms await clarification. Given a radical quenching mechanism, beta-carotene should block tumor promotion, but more typically the site of action is progression and an even later role in invasion has not been ruled out. Some antineoplastic actions of carotenoids (such as increased rejection of fibrosarcomas in mice) are attributed to immunoenhancement; others may reflect conversion to retinoids and subsequent gene regulation. Carotenoids other than beta-carotene may act at an earlier stage of carcinogenesis or be more effective as anticarcinogens at certain target sites. As scavengers of hydroxyl radicals, canthaxanthin and astaxanthin are more effective than beta-carotene. Canthaxanthin is sometimes more effective than beta-carotene in chemoprevention, but it is sometimes completely ineffective. Lycopene quenches singlet oxygen more than twice as effectively as beta-carotene. However, the antineoplastic actions of lycopene or astaxanthin remain untested. Explorations of the interactions of carotenoids with other nutrients are just beginning. Dietary fat increases absorption of carotene but decreases antineoplastic effectiveness. Research is hampered by technical problems, including the unavailability of rigorous controls, the instability of carotenoids, and the heterogeneous phase structure induced by hydrophobic compounds in aqueous media. Areas of current controversy and promising approaches for future research are identified.
β-胡萝卜素通过淬灭光活化物质,保护卟啉症患者和小鼠免受光氧化性皮炎的侵害。β-胡萝卜素在体内的其他作用是基于其在体外清除自由基的能力来解释的。例如,在用四氯化碳处理的豚鼠中,β-胡萝卜素可减少戊烷和乙烷的生成。流行病学研究将血清β-胡萝卜素水平低与肺癌和其他癌症风险升高联系起来,在干预试验中,β-胡萝卜素可减少癌前病变。然而,剂量/反应关系尚未完全明确,抗肿瘤机制有待阐明。鉴于自由基淬灭机制,β-胡萝卜素应能阻止肿瘤促进,但更典型的作用部位是进展期,甚至在侵袭中的后期作用也未被排除。类胡萝卜素的一些抗肿瘤作用(如小鼠纤维肉瘤排斥反应增加)归因于免疫增强;其他作用可能反映了向视黄醇的转化及随后的基因调控。除β-胡萝卜素外的其他类胡萝卜素可能在致癌作用的早期阶段发挥作用,或在某些靶位点作为抗癌剂更有效。作为羟基自由基的清除剂,角黄素和虾青素比β-胡萝卜素更有效。角黄素在化学预防中有时比β-胡萝卜素更有效,但有时则完全无效。番茄红素淬灭单线态氧的效率是β-胡萝卜素的两倍多。然而,番茄红素或虾青素的抗肿瘤作用尚未得到测试。类胡萝卜素与其他营养素相互作用的探索才刚刚开始。膳食脂肪会增加胡萝卜素的吸收,但会降低抗肿瘤效果。研究受到技术问题的阻碍,包括缺乏严格的对照、类胡萝卜素的不稳定性以及水性介质中疏水化合物诱导的异相结构。确定了当前存在争议的领域和未来研究的有前景的方法。